These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 36553544)

  • 1. Optimal microRNA Sequencing Depth to Predict Cancer Patient Survival with Random Forest and Cox Models.
    Jardillier R; Koca D; Chatelain F; Guyon L
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer survival classification using integrated data sets and intermediate information.
    Kim S; Park T; Kon M
    Artif Intell Med; 2014 Sep; 62(1):23-31. PubMed ID: 24997860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung.
    He SY; Xi WJ; Wang X; Xu CH; Cheng L; Liu SY; Meng QQ; Li B; Wang Y; Shi HB; Wang HJ; Wang ZZ
    Med Sci Monit; 2019 May; 25():3941-3956. PubMed ID: 31132294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of lasso-like penalized Cox models with tumor profiling improves prediction over clinical data alone and benefits from bi-dimensional pre-screening.
    Jardillier R; Koca D; Chatelain F; Guyon L
    BMC Cancer; 2022 Oct; 22(1):1045. PubMed ID: 36199072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tumor microenvironment-related mRNA-ncRNA signature for prediction early relapse and chemotherapeutic sensitivity in early-stage lung adenocarcinoma.
    Gao Z; Han H; Zhao Y; Yuan H; Zheng S; Zhang Y; Chen H
    J Cancer Res Clin Oncol; 2021 Nov; 147(11):3195-3209. PubMed ID: 34291356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel 14-gene signature for overall survival in lung adenocarcinoma based on the Bayesian hierarchical Cox proportional hazards model.
    Sun N; Chu J; Hu W; Chen X; Yi N; Shen Y
    Sci Rep; 2022 Jan; 12(1):27. PubMed ID: 34996932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia.
    Shi M; Xu G
    BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
    Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
    PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-omics facilitated variable selection in Cox-regression model for cancer prognosis prediction.
    Liu C; Wang X; Genchev GZ; Lu H
    Methods; 2017 Jul; 124():100-107. PubMed ID: 28627406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of microRNA expression in completely resected lung adenocarcinoma and the associated response to erlotinib.
    Yan G; Yao R; Tang D; Qiu T; Shen Y; Jiao W; Ge N; Xuan Y; Wang Y
    Med Oncol; 2014 Oct; 31(10):203. PubMed ID: 25192889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tumor suppressor miRNAs by integrative miRNA and mRNA sequencing of matched tumor-normal samples in lung adenocarcinoma.
    Yu N; Yong S; Kim HK; Choi YL; Jung Y; Kim D; Seo J; Lee YE; Baek D; Lee J; Lee S; Lee JE; Kim J; Kim J; Lee S
    Mol Oncol; 2019 Jun; 13(6):1356-1368. PubMed ID: 30913346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of survival and recurrence in patients with pancreatic cancer by integrating multi-omics data.
    Baek B; Lee H
    Sci Rep; 2020 Nov; 10(1):18951. PubMed ID: 33144687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Distributed Classifier for MicroRNA Target Prediction with Validation Through TCGA Expression Data.
    Ghoshal A; Zhang J; Roth MA; Xia KM; Grama AY; Chaterji S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(4):1037-1051. PubMed ID: 29993641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genetic variation in microRNA target site of KRT81 gene is associated with survival in early-stage non-small-cell lung cancer.
    Lee SY; Choi JE; Jeon HS; Hong MJ; Choi YY; Kang HG; Yoo SS; Lee EB; Jeong JY; Lee WK; Lee J; Cha SI; Kim CH; Kim YT; Jheon S; Son JW; Park JY
    Ann Oncol; 2015 Jun; 26(6):1142-1148. PubMed ID: 25716425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Which model is better in predicting the survival of laryngeal squamous cell carcinoma?: Comparison of the random survival forest based on machine learning algorithms to Cox regression: analyses based on SEER database.
    Sun H; Wu S; Li S; Jiang X
    Medicine (Baltimore); 2023 Mar; 102(10):e33144. PubMed ID: 36897699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Survival Analysis of mRNA and microRNA Signature of Patients with Breast Cancer Based on Cox Model.
    Zhang W; Zhang Y
    J Comput Biol; 2020 Sep; 27(9):1486-1494. PubMed ID: 32191499
    [No Abstract]   [Full Text] [Related]  

  • 18. RNA-seq-based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia.
    Kubota H; Ueno H; Tasaka K; Isobe T; Saida S; Kato I; Umeda K; Hiwatari M; Hasegawa D; Imamura T; Kakiuchi N; Nannya Y; Ogawa S; Hiramatsu H; Takita J
    Blood Adv; 2024 Mar; 8(5):1258-1271. PubMed ID: 38127276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma.
    Meng W; Ye Z; Cui R; Perry J; Dedousi-Huebner V; Huebner A; Wang Y; Li B; Volinia S; Nakanishi H; Kim T; Suh SS; Ayers LW; Ross P; Croce CM; Chakravarti A; Jin VX; Lautenschlaeger T
    Clin Cancer Res; 2013 Oct; 19(19):5423-33. PubMed ID: 23946296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of
    Ingrisch M; Schöppe F; Paprottka K; Fabritius M; Strobl FF; De Toni EN; Ilhan H; Todica A; Michl M; Paprottka PM
    J Nucl Med; 2018 May; 59(5):769-773. PubMed ID: 29146692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.